Stocks had worst quarter in years amid Trump tariff chaos

Image source: Adobe Stock

Stocks had worst quarter in years amid Trump tariff chaos: Monday was the last trading day of the quarter. U.S. stocks took a heavy beating during the period: Both the S&P 500 and Nasdaq Composite broke their five-quarter winning streaks and suffered their heaviest three-month losses since 2022. The Nasdaq remains in correction territory. CNBC reports.

🇺🇸 What we know and don’t know about Trump’s April 2 tariffs: President Donald Trump has described this coming Wednesday as “Liberation Day” as he touts the new taxes on imported goods that his administration plans to unveil on that day. The extent of these tariffs appears in flux at the moment, as multiple published reports say Trump in recent days has pushed his team to take a more aggressive approach than administration officials had been outlining a week or two ago. MarketWatch reports.

🏆 Another day, another record high for gold. Here’s what may spark a big pullback: Gold prices saw another strong rally Monday, with prices continuing their run to record highs, but analysts warned that prices may soon see a pullback, despite uncertainty surrounding U.S. tariffs set for April 2 that has been supportive for the safe-haven asset. MarketWatch reports.

💻 Is Google at risk of becoming irrelevant? Alphabet’s stock drop draws comparison to Kodak: Since ChatGPT burst onto the scene two and a half years ago, Wall Street has wondered whether it presented a major threat to Google’s search business. And with Alphabet’s stock now 25% off its highs, a Melius Research analyst is exploring that question with a bit more intensity. MarketWatch reports.

💊 Novo Nordisk shares post the biggest monthly decline since 2002: Europe’s largest pharmaceutical firm, Novo Nordisk, saw its stocks tumble 27% in March, marking their worst monthly performance since July 2002. Yahoo Finance reports.

💰 OpenAI finalizes $40 billion funding at $300 billion value: OpenAI said on Monday it would raise up to $40 billion in a new funding round led by SoftBank Group at a $300 billion valuation to advance AI research, expand computational infrastructure and enhance its tools. Yahoo Finance reports.

⚖️ US judge rejects J&J's $10 billion baby powder settlement: A U.S. bankruptcy judge on Monday rejected Johnson & Johnson's $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time the company's bankruptcy strategy has failed in court. Reuters reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM Eastern Time)
Benzinga reports.

1) $RSLS: Reshape Lifesciences
Total gain: +169.18%

2) $BIAF: bioAffinity Technologies
Total gain: +141.19%

3) $GATE: Marblegate Acquisition
Total gain: +77.15%

4) $NUTX: Nutex Health
Total gain: +42.41%

5) $ICCT: iCoreConnect
Total gain: +37.05%

*Estimate and Actual numbers represent Earnings Per Share in US Dollars

NCNO: Ncino
4Q 2025After Market Close
Estimate: 0.190
Actual: N/A

NG: Novagold Resources
1Q 2025Before Market Open
Estimate: -0.060
Actual: N/A

SPWH: Sportsman's Warehouse
4Q 2024After Market Close
Estimate: -0.060
Actual: N/A

Time (ET) / Report / Period

9:00 am - Richmond Fed President Thomas Barkin speaks
9:45 am - S&P final U.S. manufacturing PMI - March

“The greatest investment reward comes to those who research and reach decisions slowly, but act promptly.”

- Philip Fisher

Sourced in:
“Common Stocks and Uncommon Profits”, by Philip Fisher, published in 1958